Factor IX Grifols® 50 IU/ml (500 IU/10 ml) Factor IX Grifols® 50 IU/ml (250 IU/5 ml) Injection United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

factor ix grifols® 50 iu/ml (500 iu/10 ml) factor ix grifols® 50 iu/ml (250 iu/5 ml) injection

alhayat pharmaceuticals spain - 1 kit [1 lyophilised glass vial+1 pf syringe solvent of 10 ml+1 vial adaptor+1 syringe filter+2 alcohol swabs+1 butterfly needle - injection - factor ix grifols® 50 iu/ml (250 iu/5 ml) - cardiovascular system-antifibrinolytics , haemostatics

Prolastin-C alpha1- proteinase inhibitor (human) 1000 mg powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

prolastin-c alpha1- proteinase inhibitor (human) 1000 mg powder for injection vial with diluent vial

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - diluent, not applicable - excipient ingredients: - prolastin-c is an alpha-1-proteinase inhibitor (human, alpha1-pi) indicated to increase serum alpha1-pi levels in adults with congenital deficiency of alpha-1 antitrypsin and with clinically significant emphysema (fev1 less than 80%). the data for clinical efficacy of prolastin-c is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials. clinical trials have only included patients who were not smoking.

PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

prolastin c liquid alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - solution - excipient ingredients: monobasic sodium phosphate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1-antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.